NexgenRx Inc. (TSXV:NXG)
0.4500
-0.0100 (-2.17%)
Jun 9, 2026, 2:22 PM EST
NexgenRx Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.71 | 4.78 | 1.71 | 1.88 | 1.77 | 2.32 |
Cash & Short-Term Investments | 4.71 | 4.78 | 1.71 | 1.88 | 1.77 | 2.32 |
Cash Growth | 148.67% | 180.05% | -9.12% | 6.22% | -23.74% | 188.92% |
Accounts Receivable | 1.07 | 0.73 | 0.82 | 0.73 | 0.41 | 0.48 |
Other Receivables | - | - | 0.05 | 0.05 | - | - |
Total Trade Receivables | 1.07 | 0.73 | 0.87 | 0.78 | 0.41 | 0.48 |
Other Current Assets | 31.02 | 26.9 | 22.07 | 20.69 | 15.83 | 18.03 |
Total Current Assets | 36.81 | 32.4 | 24.65 | 23.34 | 18 | 20.83 |
Net Property, Plant & Equipment | 0.74 | 0.8 | 0.83 | 0.81 | 0.84 | 0.5 |
Other Intangible Assets | 1.24 | 1.4 | 2.33 | 3.15 | 4.1 | 5.12 |
Goodwill | 1.08 | 1.08 | 1.24 | 1.24 | 1.24 | 1.24 |
Long-Term Investments | 0.42 | 0.37 | 0.18 | - | - | - |
Other Long-Term Assets | 0.58 | 0.56 | 1.24 | 1.66 | 1.57 | 1.74 |
Total Assets | 40.86 | 36.6 | 30.46 | 30.2 | 25.75 | 29.44 |
Accounts Payable | 1 | 1.98 | 0.5 | 1.18 | 0.92 | 1.41 |
Current Portion of Leases | 0.06 | 0.08 | 0.11 | 0.06 | 0.04 | 0.23 |
Other Current Liabilities | 30.7 | 26.63 | 21.8 | 20.84 | 15.54 | 17.91 |
Total Current Liabilities | 31.76 | 28.69 | 22.41 | 22.08 | 16.51 | 19.55 |
Long-Term Leases | 0.29 | 0.29 | 0.43 | 0.4 | 0.39 | 0.17 |
Total Long-Term Liabilities | 0.29 | 0.29 | 0.43 | 0.4 | 0.39 | 0.17 |
Total Liabilities | 32.04 | 28.98 | 22.84 | 22.48 | 16.9 | 19.72 |
Preferred Stock | 1.65 | 1.65 | 1.65 | 1.65 | 1.65 | 1.65 |
Common Stock | 4.01 | 4.01 | 4.01 | 3.82 | 19.29 | 19.29 |
Additional Paid-in Capital | 4.4 | 4.4 | 4.39 | 4.38 | 4.35 | 4.3 |
Retained Earnings | -1.24 | -2.44 | -2.43 | -2.14 | -16.43 | -15.53 |
Shareholders' Equity | 8.82 | 7.62 | 7.62 | 7.71 | 8.85 | 9.71 |
Total Liabilities & Equity | 40.86 | 36.6 | 30.46 | 30.2 | 25.75 | 29.44 |
Total Debt | 0.35 | 0.37 | 0.53 | 0.46 | 0.43 | 0.4 |
Net Cash (Debt) | 4.37 | 4.41 | 1.17 | 1.41 | 1.33 | 1.92 |
Net Cash Growth | -0.98% | 276.44% | -17.18% | 6.03% | -30.33% | - |
Net Cash Per Share | 0.06 | 0.06 | 0.01 | 0.02 | 0.02 | 0.03 |
Book Value | 8.82 | 7.62 | 7.62 | 7.71 | 8.85 | 9.71 |
Book Value Per Share | 0.11 | 0.10 | 0.10 | 0.11 | 0.13 | 0.13 |
Tangible Book Value | 6.5 | 5.14 | 4.06 | 3.33 | 3.51 | 3.36 |
Tangible Book Value Per Share | 0.08 | 0.07 | 0.05 | 0.05 | 0.05 | 0.04 |